HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction (Q34687799)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction |
scientific article |
Statements
1 reference
HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction (English)
1 reference
Eszter Papp
Hakimeh Mohammadi
Mark H Yudin
Rajiv Shah
Jay MacGillivray
Michael Silverman
1 reference